Table 2. Current update on clinical trials of LF.
Identifier No. |
Types of diseases |
Estimated enrollment |
Primary purpose |
Phase |
|
NCT04094597 |
Neonatal sepsis |
200 participants |
Prevention |
Early Phase 1 |
|
NCT03431558 |
Neonatal sepsis Necrotizing enterocolitis |
300 participants |
Prevention |
Phase 3 |
|
NCT03163212 |
Safety issues Tolerance Very low birth weight infant |
20 participants |
Treatment |
Early Phase 1 |
|
NCT04445948 |
Helicobacter pylori infection |
400 participants |
Treatment |
Phase 4 |
|
NCT03481790 |
Iron deficiency anemia of pregnancy |
200 participants |
Treatment |
Phase 2 |
|
NCT03202615 |
Anemia during pregnancy |
130 participants |
Treatment |
Phase 4 |
|
NCT04267653 |
Iron deficiency anemia |
96 participants |
Treatment |
Phase 4 |
|
NCT02959229 |
Neonatal sepsis |
180 participants |
Prevention |
Phase 4 |
|
NCT04432935 |
Poliomyelitis |
754 participants |
Prevention |
N/A |
|
NCT01525316 |
Late-onset neonatal sepsis |
414 participants |
Prevention |
Phase 3 |
|
NCT02626104 |
Antibiotic-associated diarrhoea |
156 participants |
Prevention |
Phase 2 |
|
NCT01264536 |
Sepsis |
190 participants |
Prevention |
Phase 2 |
|
NCT03866837 |
Iron-deficiency |
288 participants |
Treatment |
N/A |
|
NCT03367013 |
Preterm infant Very low birth weight infant Morbidity; newborn |
500 participants |
Prevention |
Phase 3 |
|
NCT04435574 |
Anemia, iron deficiency |
90 participants |
Treatment |
Phase 4 |
|
NCT01221844 |
Pregnancy Iron deficiency Iron deficiency anemia |
300 participants |
Treatment |
Phase 4 |
|
NCT03940430 |
Iron deficiency anemia |
90 participants |
Treatment |
Phase 3 |
|
NCT01266629 |
Crohn's disease |
40 participants |
|
N/A |
|
NCT00429325 |
Acute diarrhea |
400 participants |
|
N/A |
|
NCT00937014 |
Infant nutrition |
180 participants |
|
N/A |
|
NCT03262402 |
HIV/AIDS Periodontal diseases |
22 participants |
Treatment |
N/A |
|
NCT01700725 |
Persian-gulf syndrome Chronic sinusitis Fatigue Acute sinusitis |
40 participants |
Treatment |
Phase 2 |
|
NCT00630656 |
Severe sepsis |
190 participants |
Treatment |
Phase 2 |
|